These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 2990144)

  • 1. Difference of lectin binding sites of secretory granules between normal pituitary and adenoma cells.
    Hori T; Nishiyama F; Anno Y; Adachi S; Numata H; Hokama Y; Muraoka K; Hirano H
    Acta Neuropathol; 1985; 66(3):177-83. PubMed ID: 2990144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of concanavalin A binding sites in human pituitary adenoma cells as revealed by HRP-labelling method.
    Hori T; Nishiyama F; Teramoto A; Matsutani M; Takakura K; Hirano H
    Acta Neuropathol; 1983; 62(1-2):59-66. PubMed ID: 6318506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in glycoconjugates of adrenocorticotropic hormone-secretory granules between nonadenomatous pituitary cells and adenoma cells as detected by double labeling.
    Hori T; Nishiyama F; Anno Y; Tanaka S; Watanabe T; Hirano H
    Neurosurgery; 1988 Jul; 23(1):52-7. PubMed ID: 2845295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.
    Bassetti M; Spada A; Arosio M; Vallar L; Brina M; Giannattasio G
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.
    Bassetti M; Brina M; Spada A; Giannattasio G
    J Endocrinol Invest; 1989 Nov; 12(10):705-12. PubMed ID: 2614009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas.
    Tahara S; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 1999 Jun; 12(6):627-34. PubMed ID: 10392640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoelectron microscopy for growth hormone and prolactin in pituitary adenomas.
    Tomita T; Watanabe I; Rengachary SS
    Hum Pathol; 1987 Apr; 18(4):367-74. PubMed ID: 3549533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light and electron microscopic observation of the same mammosomatotroph cell in a mixed growth hormone- and prolactin-secreting pituitary adenoma--case report.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T
    Neurol Med Chir (Tokyo); 1993 Apr; 33(4):238-41. PubMed ID: 7685856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of secretory granules of silent pituitary adenomas.
    Holck S; Wewer UM; Albrechtsen R
    Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-bindings in pituitary adenomas and normal pituitaries.
    Behncken A; Saeger W
    Pathol Res Pract; 1991 Jun; 187(5):629-31. PubMed ID: 1923958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of cytokeratins in endocrine cells of the human pituitary gland and in pituitary adenomas.
    Höfler H; Denk H; Walter GF
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(4):359-68. PubMed ID: 6208678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
    Holm R; Nesland JM; Attramadal A; Reinli S; Johannessen JV
    J Submicrosc Cytol Pathol; 1989 Apr; 21(2):339-50. PubMed ID: 2752363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical colocalization of growth hormone (GH) and alpha subunit in human GH secreting pituitary adenomas.
    Osamura RY; Watanabe K
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):323-30. PubMed ID: 2442884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peanut agglutinin binding to human prolactin-producing pituitary adenomas.
    Kurosaki M; Hori T; Takata K; Kawakami H; Hirano H
    Acta Neuropathol; 1995; 89(6):475-82. PubMed ID: 7676803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathobiologic study of pituitary tumors: report of 62 cases with a review of the recent literature.
    Challa VR; Marshall RB; Hopkins MB; Kelly DL; Civantos F
    Hum Pathol; 1985 Sep; 16(9):873-84. PubMed ID: 2993152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenomas producing growth hormone in acromegalic patients.
    Smallman LA; Dunn PJ; Curran RC; London DR
    J Clin Pathol; 1984 Apr; 37(4):382-9. PubMed ID: 6368603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory granules of pituitary adenomas: quantitative study of hormonal antigenicity.
    Kamitani H; Masuzawa H; Kanazawa I; Kubo T
    Acta Neuropathol; 2000 Mar; 99(3):263-70. PubMed ID: 10663968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry.
    Lloyd RV; Anagnostou D; Cano M; Barkan AL; Chandler WF
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1103-10. PubMed ID: 3286671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.